1. Home
  2. SQFT vs CNSP Comparison

SQFT vs CNSP Comparison

Compare SQFT & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQFT
  • CNSP
  • Stock Information
  • Founded
  • SQFT 1999
  • CNSP 2017
  • Country
  • SQFT United States
  • CNSP United States
  • Employees
  • SQFT N/A
  • CNSP N/A
  • Industry
  • SQFT Real Estate Investment Trusts
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQFT Real Estate
  • CNSP Health Care
  • Exchange
  • SQFT Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • SQFT 8.3M
  • CNSP 6.5M
  • IPO Year
  • SQFT 2020
  • CNSP 2019
  • Fundamental
  • Price
  • SQFT $0.63
  • CNSP $0.10
  • Analyst Decision
  • SQFT
  • CNSP Strong Buy
  • Analyst Count
  • SQFT 0
  • CNSP 1
  • Target Price
  • SQFT N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • SQFT 25.6K
  • CNSP 11.0M
  • Earning Date
  • SQFT 02-18-2025
  • CNSP 03-31-2025
  • Dividend Yield
  • SQFT N/A
  • CNSP N/A
  • EPS Growth
  • SQFT N/A
  • CNSP N/A
  • EPS
  • SQFT N/A
  • CNSP N/A
  • Revenue
  • SQFT $18,586,052.00
  • CNSP N/A
  • Revenue This Year
  • SQFT N/A
  • CNSP N/A
  • Revenue Next Year
  • SQFT N/A
  • CNSP N/A
  • P/E Ratio
  • SQFT N/A
  • CNSP N/A
  • Revenue Growth
  • SQFT 5.44
  • CNSP N/A
  • 52 Week Low
  • SQFT $0.47
  • CNSP $0.08
  • 52 Week High
  • SQFT $1.39
  • CNSP $23.90
  • Technical
  • Relative Strength Index (RSI)
  • SQFT 42.13
  • CNSP 50.33
  • Support Level
  • SQFT $0.64
  • CNSP $0.09
  • Resistance Level
  • SQFT $0.72
  • CNSP $0.10
  • Average True Range (ATR)
  • SQFT 0.05
  • CNSP 0.01
  • MACD
  • SQFT -0.00
  • CNSP 0.00
  • Stochastic Oscillator
  • SQFT 17.14
  • CNSP 52.85

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: